Please be aware that all information shared here at Canada Pharmacy has been medically reviewed and fact-checked for accuracy. These verifications are made by board-certified medical professionals who have the authority required to state that information related to medical conditions, symptoms, procedures and tests, and standard treatment protocols is valid and truthful. This is based on current guidelines and consensuses shared amongst medical professionals, and in representation of the latest research.
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Sign up to get exclusive coupon discounts and be the first to be notified when we have this product available.
Ultibro Breezhaler is a combination of indacaterol and glycopyrronium bromide, used to provide long-term relief for adults with chronic obstructive pulmonary disease (COPD). It works by acting as an ultra-long-acting beta-adrenoceptor agonist and a long-acting muscarinic antagonist, which help expand the airways and make it easier to breathe. It is used as a maintenance treatment to help improve the quality of life for individuals living with COPD.
One inhalation of Ultibro (glycopyrrolate 15.6 mcg-indacaterol 27.5 mcg) is typically taken orally once per day. The medication is administered using an inhaler device, which requires you to inhale the content of one capsule per dose. Do not take more than the recommended dosage or use more frequently, as it may lead to adverse effects. Keep in mind that this medication is intended for treating COPD and should not be used to treat asthma, as doing so may increase the risk of asthma-related death.
Ultibro Breezhaler is a combination medication composed of two active substances: indacaterol (85 micrograms) and glycopyrronium (43 micrograms). Indacaterol maleate is an ultra long-acting beta-adrenoceptor agonist (ultra-LABA), while glycopyrronium bromide aids in further lung function improvement and symptom relief.
The following list details some conditions and situations in which the use of Ultibro Breezhaler is not recommended:
Ultibro Breezhaler may cause side effects. Common side effects may include cough, sore throat, runny or stuffy nose, and headache. Additionally, some people may experience frequent urination, dizziness, and indigestion. It is important to use the medication as prescribed and consult your health care professional if these side effects persist or worsen.
More serious side effects of Ultibro Breezhaler may require immediate medical attention. These can include an allergic reaction, which may present as hives, difficulty breathing, or swelling of the face, lips, tongue, or throat. Additionally, severe eye problems or worsening of lung symptoms may occur. If you or a loved one is taking Ultibro Breezhaler and experiences any serious side effects, seek medical advice immediately.